• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACR
Click for more information
1.64% 6.0¢

ACRUX LIMITED

Market Cap $17.44M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto(estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ACR
Ann: Launch of Dapsone 5%, Gel in the United States 		24/04/24 40 11K
24/04/24 Last post  mybestaccount Comments Created with Sketch.  40  Views Created with Sketch.  11K 
ACR
Efinaconazole Topical Solution 		02/04/24 2 728
02/04/24 Last post  jetrodder Comments Created with Sketch.  2  Views Created with Sketch.  728 
ACR
onward and upward 		27/03/24 24 6.2K
27/03/24 Last post  mybestaccount Comments Created with Sketch.  24  Views Created with Sketch.  6.2K 
ACR
Ann: Appendix 3Y Dobinson 		05/03/24 1 594
05/03/24 Last post  Slogger Comments Created with Sketch.  1  Views Created with Sketch.  594 
ACR
Ann: Appendix 3Y Brumley 		05/03/24 0 181
05/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  181 
ACR
Ann: Application for quotation of securities - ACR 		05/03/24 0 191
05/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  191 
ACR
Ann: Appendix 4D and Half Year Accounts 		29/02/24 8 2.4K
29/02/24 Last post  jetrodder Comments Created with Sketch.  8  Views Created with Sketch.  2.4K 
ACR
Ann: Investor Presentation Half Year Accounts 		27/02/24 0 385
27/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  385 

See All Discussions arrow Created with Sketch.

Timeline

Launch of Dapsone 5%, Gel in the United States
03 Apr 08:34
 
Appendix 3Y Dobinson
05 Mar 15:12
 
Appendix 3Y Brumley
05 Mar 15:11
 
Application for quotation of securities - ACR
05 Mar 15:09
 
Investor Presentation Half Year Accounts
27 Feb 16:26
 
Appendix 4D and Half Year Accounts
27 Feb 16:25
 
View More arrow Created with Sketch.

Featured News

NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
(20min delay)
Last
6.0¢ 		Change
-0.001(1.64%) 		Mkt cap ! $17.44M
Open High Low Value Volume
6.2¢ 6.2¢ 5.9¢ $11.22K 185.0K

Buyers (Bids)

No. Vol. Price($)
1 12103 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 79125 1
View Market Depth
Last trade - 15.44pm 26/04/2024 (20 minute delay) ?
Last
5.9¢ 		  Change
-0.001 ( 3.28 %)
Open High Low Volume
6.1¢ 6.1¢ 5.9¢ 11668
Last updated 12.47pm 26/04/2024 ?
ACR (ASX) Chart

Top Stories

Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Lithium Universe reveals plan to fill a 'gap' in the North American market Lithium Universe has flagged its Québec Lithium Processing Hub in Canada as a key producer of battery-grade lithium to the North American market..
Are there gains to be made with the grocery giants? There is a growing storm of controversy around Coles (ASX:COL) and Woolworths (ASX:WOW) as they face intense scrutiny over price hikes and supplier pressures in a Senate inquiry. This raises an interesting question as to whether investors should cut ties with these corporate giants or wheth...
BHP confirms £31.1B takeover bid for Anglo American BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation of a potential deal.which had unsettled shareholder groups and financial firms in London, and provoked criticism from a South African government minister.
Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy The big thematics and headlines that drove the ASX this week, plus, the headlines I think investors ought to be keeping eyes on.

Featured News

NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.